Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
2.
Mem. Inst. Oswaldo Cruz ; 96(3): 381-383, Apr. 2001. ilus, tab
Article in English | LILACS | ID: lil-282849

ABSTRACT

Biomphalaria occidentalis Paraense, 1981 from Varzea das Flores dam, MG, Brazil, was exposed to infection with Schistosoma mansoni. Individual infection was performed with 140 B. occidentalis and 100 B. glabrata snails using LE and SJ strains. Two groups of B. occidentalis were killed after seven day-miracidia exposure to detect S. mansoni DNA, through the low stringency polymerase chain reaction (LS-PCR), and were negative. The infection rates were 69.2 percent (LE strain) and 96.7 percent (SJ strain) for B. glabrata and 0 percent for B. occidentalis. LS-PCR enabled early resistance diagnosis


Subject(s)
Animals , Biomphalaria/parasitology , Host-Parasite Interactions , Polymerase Chain Reaction/methods , Schistosoma mansoni/pathogenicity , Schistosomiasis mansoni , DNA, Helminth/analysis , Time Factors
3.
Rev. Soc. Bras. Med. Trop ; 29(5): 467-76, Sept.-Oct. 1996. tab, ilus
Article in Portuguese | LILACS | ID: lil-187191

ABSTRACT

Ten inhabitants of Itaquara, Bahia, Brazil treated with oxamniquine and subsequently praziquantel were not cured. Schistosoma mansoni isolates derived from these patients were studied. Snails were infected with miracidia derived from the feces of these patients and the cercariae produced used to infect albino mice. The animals were then treated with a single oral dose of oxamniquine (25, 50 and 100mg/kg) or praziquantel (100, 200 and 400 mg/kg). The response to chemotherapy was significantly different in some of the isolates although it was not possible to characterize any of them as resistant. In addition, DNA analysis of the isolates by means of ®Random Amplified Polymorphic DNA® indicated a low degree of variability as compared with a laboratory strain, LE. Thus, it was not possible to characterize these organisms at a genetic level as a distinct strain.


Subject(s)
Adolescent , Animals , Child , Humans , Mice , Antiprotozoal Agents/pharmacology , Oxamniquine/pharmacology , Praziquantel/pharmacology , Schistosoma mansoni/drug effects , Schistosomiasis mansoni/parasitology , Antiprotozoal Agents/therapeutic use , Schistosomiasis mansoni/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL